Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Identify situations where TRI provides a fuller view of performance than a price index, especially when dividends and compounding matter to total returns.
26,863 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...
The market has been pushing toward higher rates, and the phrase uh-oh! probability fomc rate is popping up in convers...
Palantir’s stock has moved little over the past year despite strong revenue growth, reigniting a debate about michael...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
Costco's strength goes beyond its membership fees. This article reveals how Kirkland Signature quietly grew into Cost...
Oil markets are heating up as supply constraints tighten. Here are three solid stock ideas to consider before prices ...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
Nike's quarterly results offer more than sneaker news. This guide breaks down the numbers, the stock reaction, and ac...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Midweek headlines can turn crypto markets on a dime. This piece explains the drivers behind bitcoin sinking wednesday...